rs119472028
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The ENST00000389039.11(DUOX2):c.2524C>T(p.Arg842Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000186 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R842R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000389039.11 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUOX2 | NM_001363711.2 | c.2524C>T | p.Arg842Ter | stop_gained | 19/34 | ENST00000389039.11 | NP_001350640.1 | |
DUOX2 | NM_014080.5 | c.2524C>T | p.Arg842Ter | stop_gained | 19/34 | NP_054799.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUOX2 | ENST00000389039.11 | c.2524C>T | p.Arg842Ter | stop_gained | 19/34 | 1 | NM_001363711.2 | ENSP00000373691 | P4 | |
DUOX2 | ENST00000603300.1 | c.2524C>T | p.Arg842Ter | stop_gained | 19/34 | 1 | ENSP00000475084 | A1 | ||
DUOX2 | ENST00000558383.1 | n.4255C>T | non_coding_transcript_exon_variant | 13/17 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251374Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135878
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727236
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74320
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 05, 2023 | This sequence change creates a premature translational stop signal (p.Arg842*) in the DUOX2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DUOX2 are known to be pathogenic (PMID: 12110737, 18765513, 21565790, 24423310, 24735383). This variant is present in population databases (rs119472028, gnomAD 0.008%). This premature translational stop signal has been observed in individual(s) with autosomal recessive thyroid dyshormonogenesis (PMID: 16134168, 27108200). ClinVar contains an entry for this variant (Variation ID: 4064). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2018 | The R842X variant in the DUOX2 gene has been reported previously as compound heterozygous in unrelated individuals with transient or persistent congenital hypothyroidism (Vigone et al., 2005; Fu et al., 2015). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R842X variant is observed in 14/277130 (0.005%) alleles in large population cohorts, and no individuals were reported to be homozygous (Lek et al., 2016). We interpret R842X as a pathogenic variant. - |
Thyroid dyshormonogenesis 6 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 23, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2005 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at